Early studies indicated a primary pathogenic role for IFN-γ-producing Th1 cells, however, this view has been challenged in recent years when IL-17-producing Th17 cells have been viewed as the main actors in the course of MS. This evidence concerns the gene IL17A and myeloid sarcoma.